SouthState Corp’s Charles River Laboratories CRL Stock Holding History

SouthState Corp’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.4K	Buy	15 +3	+25%	+$534	﹤0.01%	857
2026 Q1	$2.07K	Hold	12	–	–	﹤0.01%	895
2025 Q4	$2.39K	Sell	12 -5	-29%	-$907	﹤0.01%	950
2025 Q3	$2.66K	Buy	17 +3	+21%	+$476	﹤0.01%	884
2025 Q2	$2.13K	Sell	14 -65	-82%	-$8.67K	﹤0.01%	1082
2025 Q1	$11.9K	Buy	79 +50	+172%	+$8.38K	﹤0.01%	796
2024 Q4	$5.35K	Buy	+29	New	+$5.59K	﹤0.01%	565
2022 Q3	–	Sell	-40	Closed	-$9K	–	694
2022 Q2	$9K	Buy	+40	New	+$9.77K	﹤0.01%	588

Other funds holding CRL

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

SouthState Corp's CRL Position: Q2 2026 in Review

SouthState Corp increased its Charles River Laboratories (CRL) stake by 25% in Q2 2026, buying an estimated $534 and bringing the position to 15 shares worth $3.4K. The position accounts for ﹤0.01% of the portfolio, ranked #857.

SouthState Corp first reported a position in CRL in Q2 2022 and has held it in 8 quarters since. The position peaked at $11.9K in Q1 2025. 563 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

SouthState Corp held 15 shares of Charles River Laboratories worth $3.4K as of Q2 2026.
SouthState Corp bought 3 Charles River Laboratories shares in Q2 2026, an estimated $534.
Charles River Laboratories made up ﹤0.01% of SouthState Corp's portfolio in Q2 2026, its #857 holding.
SouthState Corp first reported a position in Charles River Laboratories in Q2 2022 and has held it in 8 quarters since.
SouthState Corp's Charles River Laboratories position peaked at $11.9K in Q1 2025.
563 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on SouthState Corp's 13F filing for Q2 2026, filed 6 Aug 2026.